GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ThermoGenesis Holdings Inc (NAS:THMO) » Definitions » Cyclically Adjusted PS Ratio

ThermoGenesis Holdings (ThermoGenesis Holdings) Cyclically Adjusted PS Ratio : 0.00 (As of Apr. 27, 2024)


View and export this data going back to 1987. Start your Free Trial

What is ThermoGenesis Holdings Cyclically Adjusted PS Ratio?

As of today (2024-04-27), ThermoGenesis Holdings's current share price is $0.68. ThermoGenesis Holdings's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was $1,295.35. ThermoGenesis Holdings's Cyclically Adjusted PS Ratio for today is 0.00.

The historical rank and industry rank for ThermoGenesis Holdings's Cyclically Adjusted PS Ratio or its related term are showing as below:

During the past years, ThermoGenesis Holdings's highest Cyclically Adjusted PS Ratio was 2.25. The lowest was 0.01. And the median was 0.15.

THMO's Cyclically Adjusted PS Ratio is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 2.11
* Ranked among companies with meaningful Cyclically Adjusted PS Ratio only.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

ThermoGenesis Holdings's adjusted revenue per share data for the three months ended in Dec. 2023 was $0.665. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $1,295.35 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


ThermoGenesis Holdings Cyclically Adjusted PS Ratio Historical Data

The historical data trend for ThermoGenesis Holdings's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ThermoGenesis Holdings Cyclically Adjusted PS Ratio Chart

ThermoGenesis Holdings Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.04 0.02 0.01 - -

ThermoGenesis Holdings Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of ThermoGenesis Holdings's Cyclically Adjusted PS Ratio

For the Medical Devices subindustry, ThermoGenesis Holdings's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ThermoGenesis Holdings's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ThermoGenesis Holdings's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where ThermoGenesis Holdings's Cyclically Adjusted PS Ratio falls into.



ThermoGenesis Holdings Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

ThermoGenesis Holdings's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=0.68/1295.35
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ThermoGenesis Holdings's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, ThermoGenesis Holdings's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.665/129.4194*129.4194
=0.665

Current CPI (Dec. 2023) = 129.4194.

ThermoGenesis Holdings Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 1,346.000 99.695 1,747.323
201406 959.250 100.560 1,234.548
201409 913.750 100.428 1,177.532
201412 1,160.750 99.070 1,516.342
201503 1,010.500 99.621 1,312.757
201506 925.500 100.684 1,189.641
201509 564.600 100.392 727.852
201512 658.800 99.792 854.389
201603 472.000 100.470 608.000
201606 425.714 101.688 541.810
201609 289.769 101.861 368.166
201612 182.045 101.863 231.293
201703 147.818 102.862 185.982
201706 159.136 103.349 199.279
201709 139.500 104.136 173.370
201712 133.818 104.011 166.508
201803 77.792 105.290 95.620
201806 58.941 106.317 71.749
201809 63.531 106.507 77.198
201812 48.873 105.998 59.672
201903 53.855 107.251 64.987
201906 69.435 108.070 83.152
201909 62.431 108.329 74.585
201912 24.600 108.420 29.365
202003 34.783 108.902 41.336
202006 16.014 108.767 19.055
202009 15.805 109.815 18.627
202012 11.063 109.897 13.028
202103 5.972 111.754 6.916
202106 8.306 114.631 9.378
202109 11.917 115.734 13.326
202112 9.125 117.630 10.040
202203 9.247 121.301 9.866
202206 10.130 125.017 10.487
202209 3.043 125.227 3.145
202212 2.581 125.222 2.668
202303 2.058 127.348 2.091
202306 0.916 128.729 0.921
202309 0.876 129.860 0.873
202312 0.665 129.419 0.665

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


ThermoGenesis Holdings  (NAS:THMO) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


ThermoGenesis Holdings Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of ThermoGenesis Holdings's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


ThermoGenesis Holdings (ThermoGenesis Holdings) Business Description

Traded in Other Exchanges
Address
2711 Citrus Road, Rancho Cordova, CA, USA, 95742
ThermoGenesis Holdings Inc develops, commercializes and markets a range of automated technologies for CAR-T and other cell-based therapies. The company currently markets a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally-closed CAR-TXpress platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market. It offers the AutoXpress and BioArchive platforms for automated clinical bio-banking, PXP platform for point-of-care cell-based therapies and CAR-TXpress platform for bio-manufacturing for immuno-oncology applications.
Executives
Xiaochun Xu director 2453 S. ARCHER AVE., STE. B, CHICAGO IL 60616
Biao Xi director C/O THERMOGENESIS HOLDINGS, INC., 2711 CITRUS ROAD, RANCHO CORDOVA CA 95742
James Xu director 2453 S. ARCHER AVE, SUITE B, CHICAGO IL 60616
Haihong Zhu director 2711 CITRUS ROAD, RANCHO CORDOVA CA 95742
Debra Donaghy director C/O THERMOGENESIS HOLDINGS, INC., 2711 CITRUS RD., RANCHO CORDOVA CA 95742
Boyalife (hong Kong) Ltd 10 percent owner 2453 S. ARCHER AVE., STE. B, CHICAGO IL 60616
Thomis Joseph director MALEIZENSTRAAT 66, HERENT C9 B-3020
Boyalife Asset Holding Ii, Inc. 10 percent owner 2453 S. ARCHER AVE., SUITE B, CHICAGO IL 60616
Boyalife Group, Inc. 10 percent owner 2453 S. ARCHER AVE., SUITE B, CHICAGO IL 60616
Russell M Medford director 7935 FAWNDALE WAY, ATLANTA GA 30350
Mark Westgate director 350 CORPORATE BOULEVARD, ROBBINSVILLE NJ 08691
Jeffery Cauble officer: Principal Accounting Officer 2711 CITRUS CT., RANCHO CORDOVA CA 95742
Vivian H Liu director
Boyalife Investment Inc. 10 percent owner 2453 S. ARCHER AVE., STE. B, CHICAGO IL 60616
Mark Bagnall director 3876 BAY CENTER PLACE, HAYWARD CA 94545

ThermoGenesis Holdings (ThermoGenesis Holdings) Headlines

From GuruFocus